RESMED (BE:RME) — Market Cap & Net Worth
Market Cap & Net Worth: RESMED (RME)
RESMED (BE:RME) has a market capitalization of $23.98K (€20.51K) as of April 17, 2026. Listed on the BE stock exchange, this Germany-based company holds position #40226 globally and #4719 in its home market, demonstrating a -1.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RESMED's stock price €205.10 by its total outstanding shares 100 (100.00).
RESMED Market Cap History: 2015 to 2026
RESMED's market capitalization history from 2015 to 2026. Data shows growth from $5.23K to $23.98K (16.16% CAGR).
RESMED Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RESMED's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
RESMED's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
RESMED's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.31K | $1.84 Billion | $352.41 Million | 0.00x | 0.00x |
| 2017 | $7.74K | $2.07 Billion | $342.28 Million | 0.00x | 0.00x |
| 2018 | $10.55K | $2.34 Billion | $315.59 Million | 0.00x | 0.00x |
| 2019 | $15.17K | $2.61 Billion | $404.59 Million | 0.00x | 0.00x |
| 2020 | $19.37K | $2.96 Billion | $621.67 Million | 0.00x | 0.00x |
| 2021 | $25.97K | $3.20 Billion | $474.50 Million | 0.00x | 0.00x |
| 2022 | $22.28K | $3.58 Billion | $779.44 Million | 0.00x | 0.00x |
| 2023 | $18.00K | $4.22 Billion | $897.56 Million | 0.00x | 0.00x |
| 2024 | $25.98K | $4.69 Billion | $1.02 Billion | 0.00x | 0.00x |
Competitor Companies of RME by Market Capitalization
Companies near RESMED in the global market cap rankings as of April 17, 2026.
Key companies related to RESMED by market ranking:
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #4771 globally with a market cap of $3.25 Billion USD.
- Fuller Smith & Turner P.L.C (PINK:FTUAF): Ranked #14850 globally with a market cap of $413.74 Million USD.
- ESSO THAILAND NVDR (JAV2.SG) (STU:JAV2): Ranked #17877 globally with a market cap of $228.84 Million USD ( €195.74 Million EUR).
- Nihon Chouzai Co.Ltd (PINK:NHCZF): Ranked #19537 globally with a market cap of $162.79 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #4771 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #14850 | Fuller Smith & Turner P.L.C | PINK:FTUAF | $413.74 Million | $13.93 |
| #17877 | ESSO THAILAND NVDR (JAV2.SG) | STU:JAV2 | $228.84 Million | €0.06 |
| #19537 | Nihon Chouzai Co.Ltd | PINK:NHCZF | $162.79 Million | $16.03 |
RESMED Historical Marketcap From 2015 to 2026
Between 2015 and today, RESMED's market cap moved from $5.23K to $ 23.98K, with a yearly change of 16.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €23.98K | 0.00% |
| 2025 | €23.98K | -7.70% |
| 2024 | €25.98K | +44.30% |
| 2023 | €18.00K | -19.19% |
| 2022 | €22.28K | -14.22% |
| 2021 | €25.97K | +34.10% |
| 2020 | €19.37K | +27.70% |
| 2019 | €15.17K | +43.81% |
| 2018 | €10.55K | +36.24% |
| 2017 | €7.74K | +22.75% |
| 2016 | €6.31K | +20.50% |
| 2015 | €5.23K | -- |
End of Day Market Cap According to Different Sources
On Apr 16th, 2026 the market cap of RESMED was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.98K USD |
| MoneyControl | $23.98K USD |
| MarketWatch | $23.98K USD |
| marketcap.company | $23.98K USD |
| Reuters | $23.98K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RESMED
RESMED operates in Diversified Metals & Mining.